Chang Che-Mai, Wu Chang-Jiun, Shkurnikov Maxim, Guo Chin-Lin, Huang Wan-Chen, Tonevitsky Alexander, Chang Wei-Chiao
Master Program in Clinical Genomics and Proteomics, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Department of Pharmaceutical Sciences, School of Pharmacy, Taipei Medical University, Taipei, Taiwan.
J Biomed Sci. 2025 Apr 29;32(1):44. doi: 10.1186/s12929-025-01139-5.
The evolution of SARS-CoV-2, particularly through new variants, presents significant global health challenges due to their potential for immune evasion and reduced vaccine effectiveness. This study aims to investigate the impact of mutations in the Spike protein of Omicron EG.5 and XBB.1.16 variants on the binding affinities of viral peptides to common human leukocyte antigen (HLA) class I and II alleles across Taiwanese, British, and Russian populations. Understanding these interactions is crucial for elucidating differences in immune responses and disease severity among diverse populations.
We updated the T-CoV portal to incorporate and analyze EG.5 and XBB.1.16 variants. Binding affinities between mutated Spike protein peptides and HLA class I and II alleles were predicted and compared across the three populations. Statistical analyses, including chi-squared tests, were conducted to assess the significance of binding affinity differences across the three populations and between HLA classes.
Our findings revealed that mutations in the Spike protein had a more pronounced effect on HLA class II binding affinities than on HLA class I. While binding affinity profiles for HLA class I were largely consistent across populations, significant population-specific variations were observed for HLA class II alleles. Specifically, the British population exhibited lower proportions of tightly binding mutated peptides compared to the Taiwanese and Russian populations. Furthermore, substantial differences were identified in the binding affinity changes of mutated Spike peptides for HLA class II across Taiwanese, British, and Russian populations, as well as between the Omicron EG.5 and XBB.1.16 variants. Subsequent analyses revealed significant differences in the conservation and evolutionary trajectories of binding affinities between mutated Spike peptides and common HLA class II alleles, both between the EG.5 and XBB.1.16 variants and across the three populations for the XBB.1.16 variant.
In summary, Spike protein mutations in SARS-CoV-2 variants significantly influence immune responses by altering HLA-peptide interactions, with pronounced population-specific effects on HLA class II alleles. These findings underscore the critical role of HLA class II diversity in shaping immune responses and susceptibility to COVID-19. Integrating population-specific HLA profiles into vaccine development and public health strategies is essential for improving interventions against evolving SARS-CoV-2 variants.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的进化,尤其是通过新变种的进化,因其潜在的免疫逃逸能力和疫苗效力降低而给全球健康带来重大挑战。本研究旨在调查奥密克戎EG.5和XBB.1.16变种刺突蛋白中的突变对台湾、英国和俄罗斯人群中病毒肽与常见人类白细胞抗原(HLA)I类和II类等位基因结合亲和力的影响。了解这些相互作用对于阐明不同人群免疫反应和疾病严重程度的差异至关重要。
我们更新了T-CoV门户,以纳入并分析EG.5和XBB.1.16变种。预测并比较了三个群体中突变刺突蛋白肽与HLA I类和II类等位基因之间的结合亲和力。进行了包括卡方检验在内的统计分析,以评估三个群体之间以及HLA类别之间结合亲和力差异的显著性。
我们的研究结果显示,刺突蛋白中的突变对HLA II类结合亲和力的影响比对HLA I类的影响更为显著。虽然HLA I类的结合亲和力概况在各群体中基本一致,但HLA II类等位基因存在显著的群体特异性差异。具体而言,与台湾和俄罗斯人群相比,英国人群中紧密结合的突变肽比例较低。此外,在台湾、英国和俄罗斯人群中,以及在奥密克戎EG.5和XBB.1.16变种之间,突变刺突肽对HLA II类的结合亲和力变化存在显著差异。随后的分析揭示了在EG.5和XBB.1.16变种之间以及XBB.1.16变种的三个群体中,突变刺突肽与常见HLA II类等位基因之间结合亲和力的保守性和进化轨迹存在显著差异。
总之,SARS-CoV-2变种中的刺突蛋白突变通过改变HLA-肽相互作用显著影响免疫反应,对HLA II类等位基因具有明显的群体特异性影响。这些发现强调了HLA II类多样性在塑造免疫反应和对COVID-19易感性方面的关键作用。将群体特异性HLA谱整合到疫苗开发和公共卫生策略中对于改善针对不断进化的SARS-CoV-2变种的干预措施至关重要。